These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29118503)

  • 1. Inadvertent intralenticular dexamethasone implant: 1-year follow-up and management.
    Caglar C
    Oman J Ophthalmol; 2017; 10(3):235-237. PubMed ID: 29118503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema?
    Sekeroglu MA; Anayol MA; Koc F; Tirhis H; Ozkan SS; Yilmazbas P
    Case Rep Ophthalmol; 2016; 7(1):85-9. PubMed ID: 27293406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical removal of inadvertent intralenticular sustained-release dexamethasone implant (ozurdex) and implant one-piece posterior capsule intraocular lens.
    Albuainain A; Al Jindan M; Al Bloushi B
    Saudi J Ophthalmol; 2020; 34(2):145-147. PubMed ID: 33575542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accidental Intralenticular Injection of Ozurdex® for Branch Retinal Vein Occlusion: Intact Posterior Capsule and Resolution of Macular Edema.
    Kurt A; Durukan AH; Küçükevcilioğlu M
    Case Rep Ophthalmol Med; 2019; 2019():8630504. PubMed ID: 30809404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
    Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
    Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadvertent dexamethasone implant injection into the lens body management.
    Berarducci A; Sian IS; Ling R
    Eur J Ophthalmol; 2014; 24(4):620-2. PubMed ID: 24519508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid progression of cataract to mature stage after intravitreal dexamethasone implant injection: a case report.
    Lee JH; Park JY; Kim JS; Hwang JH
    BMC Ophthalmol; 2019 Jan; 19(1):1. PubMed ID: 30606142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal dexamethasone implant for macular edema following uncomplicated phacoemulsification.
    Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
    Eur J Ophthalmol; 2014; 24(3):387-91. PubMed ID: 24170523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.
    Coca-Robinot J; Casco-Silva B; Armadá-Maresca F; García-Martínez J
    Eur J Ophthalmol; 2014; 24(4):633-6. PubMed ID: 24519506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning and follow-up of intralenticular dexamethasone implant.
    Munteanu M; Rosca C
    J Cataract Refract Surg; 2013 Aug; 39(8):1271-4. PubMed ID: 23889870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Kaldırım HE; Yazgan S
    Int Ophthalmol; 2018 Aug; 38(4):1549-1558. PubMed ID: 28646440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-month, multicenter, parallel group comparison of dexamethasone intravitreal implant versus ranibizumab in branch retinal vein occlusion.
    Bandello F; Augustin A; Tufail A; Leaback R
    Eur J Ophthalmol; 2018 Nov; 28(6):697-705. PubMed ID: 29631435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
    Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
    J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
    Brunner M; Haueter I; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Kumar P; Sharma YR; Chandra P; Azad R; Meshram GG
    Folia Med (Plovdiv); 2019 Jun; 61(2):240-248. PubMed ID: 31301668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ozurdex completely located inside a crystallized lens - Results of 14 months.
    Baskan B; Cıcek A; Gulhan A; Gundogan M; Goktas S
    Am J Ophthalmol Case Rep; 2016 Dec; 4():38-40. PubMed ID: 29503921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.